The emerging role of interleukin-1β in autoinflammatory diseases.
National Amyloidosis Centre, University College London Medical School, London, UK. h.lachmann@medsch.ucl.ac.uk
Helen J
HJ
Lachmann
Pierre
P
Quartier
Alexander
A
So
Philip N
PN
Hawkins
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology*; D015551:Autoimmunity / Q000276:immunology*; D056587:Cryopyrin-Associated Periodic Syndromes / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors / Q000276:immunology*
D000893:Anti-Inflammatory Agents; D053583:Interleukin-1beta